114 related articles for article (PubMed ID: 38410032)
1. Screening out molecular pathways and prognostic biomarkers of ultraviolet-mediated melanoma through computational techniques.
Hossain A; Ahsan A; Hasan I; Sohel ; Khan A; Somadder PD; Monjur S; Miah S; Kibria KMK; Ahmed K; Rahman H
Int J Biol Markers; 2024 Jun; 39(2):118-129. PubMed ID: 38410032
[TBL] [Abstract][Full Text] [Related]
2. Screening and identification of potential biomarkers and therapeutic drugs in melanoma via integrated bioinformatics analysis.
Chen B; Sun D; Qin X; Gao XH
Invest New Drugs; 2021 Aug; 39(4):928-948. PubMed ID: 33501609
[TBL] [Abstract][Full Text] [Related]
3. Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis.
Chen L; Lu D; Sun K; Xu Y; Hu P; Li X; Xu F
Gene; 2019 Apr; 692():119-125. PubMed ID: 30654001
[TBL] [Abstract][Full Text] [Related]
4. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
[TBL] [Abstract][Full Text] [Related]
5. Screening and Identification of Key Biomarkers in Inflammatory Breast Cancer Through Integrated Bioinformatic Analyses.
Wu J; Lv Q; Huang H; Zhu M; Meng D
Genet Test Mol Biomarkers; 2020 Aug; 24(8):484-491. PubMed ID: 32598242
[No Abstract] [Full Text] [Related]
6. Identification of latent biomarkers in connection with progression and prognosis in oral cancer by comprehensive bioinformatics analysis.
Reyimu A; Chen Y; Song X; Zhou W; Dai J; Jiang F
World J Surg Oncol; 2021 Aug; 19(1):240. PubMed ID: 34384424
[TBL] [Abstract][Full Text] [Related]
7. Identification and validation of key genes with prognostic value in non-small-cell lung cancer via integrated bioinformatics analysis.
Wang L; Qu J; Liang Y; Zhao D; Rehman FU; Qin K; Zhang X
Thorac Cancer; 2020 Apr; 11(4):851-866. PubMed ID: 32059076
[TBL] [Abstract][Full Text] [Related]
8. Identification of key genes and biological pathways in Chinese lung cancer population using bioinformatics analysis.
Liu P; Li H; Liao C; Tang Y; Li M; Wang Z; Wu Q; Zhou Y
PeerJ; 2022; 10():e12731. PubMed ID: 35178291
[TBL] [Abstract][Full Text] [Related]
9. Identification of key candidate genes involved in melanoma metastasis.
Chen J; Wu F; Shi Y; Yang D; Xu M; Lai Y; Liu Y
Mol Med Rep; 2019 Aug; 20(2):903-914. PubMed ID: 31173190
[TBL] [Abstract][Full Text] [Related]
10. Identification of potential biomarkers with colorectal cancer based on bioinformatics analysis and machine learning.
Hammad A; Elshaer M; Tang X
Math Biosci Eng; 2021 Oct; 18(6):8997-9015. PubMed ID: 34814332
[TBL] [Abstract][Full Text] [Related]
11. Integrated Analysis of Hub Genes and Pathways In Esophageal Carcinoma Based on NCBI's Gene Expression Omnibus (GEO) Database: A Bioinformatics Analysis.
Yu-Jing T; Wen-Jing T; Biao T
Med Sci Monit; 2020 Aug; 26():e923934. PubMed ID: 32756534
[TBL] [Abstract][Full Text] [Related]
12. Identification of potential biomarkers for melanoma cancer (black tumor) using bioinformatics strategy: a study based on GEO and SRA datasets.
ALMatrafi TA; Mohammedsaleh ZM; Moawadh MS; Bassfar Z; Jalal MM; Badahdah FA; Alghamdi YS; Almasoudi HH; Hakami MA; Binshaya AS; Almohaimeed HM; Soliman MH
J Appl Genet; 2024 Feb; 65(1):83-93. PubMed ID: 37875608
[TBL] [Abstract][Full Text] [Related]
13. Exploration and validation of metastasis-associated genes for skin cutaneous melanoma.
Luan H; Jian L; He Y; Zhang T; Zhou L
Sci Rep; 2022 Jul; 12(1):13002. PubMed ID: 35906389
[TBL] [Abstract][Full Text] [Related]
14. Identification of Hub Genes Associated with Tumor-Infiltrating Immune Cells and ECM Dynamics as the Potential Therapeutic Targets in Gastric Cancer through an Integrated Bioinformatic Analysis and Machine Learning Methods.
Liu J; Cheng Z
Comb Chem High Throughput Screen; 2023; 26(4):653-667. PubMed ID: 35996248
[TBL] [Abstract][Full Text] [Related]
15. Screening and Identification of Key Biomarkers in Melanoma: Evidence from Bioinformatic Analyses.
Xia Y; Xie J; Zhao J; Lou Y; Cao D
J Comput Biol; 2021 Mar; 28(3):317-329. PubMed ID: 32985909
[TBL] [Abstract][Full Text] [Related]
16. Screening and identification of potential prognostic biomarkers in metastatic skin cutaneous melanoma by bioinformatics analysis.
Sheng Z; Han W; Huang B; Shen G
J Cell Mol Med; 2020 Oct; 24(19):11613-11618. PubMed ID: 32869947
[TBL] [Abstract][Full Text] [Related]
17. Identification of Novel Genes and Associated Drugs in Cervical Cancer by Bioinformatics Methods.
Wang D; Liu Y; Cheng S; Liu G
Med Sci Monit; 2022 Apr; 28():e934799. PubMed ID: 35428744
[TBL] [Abstract][Full Text] [Related]
18. Identification of Key Genes and Pathways in Myeloma side population cells by Bioinformatics Analysis.
Yang Q; Li K; Li X; Liu J
Int J Med Sci; 2020; 17(14):2063-2076. PubMed ID: 32922167
[No Abstract] [Full Text] [Related]
19. Employing bioinformatics analysis to identify hub genes and microRNAs involved in colorectal cancer.
Ebadfardzadeh J; Kazemi M; Aghazadeh A; Rezaei M; Shirvaliloo M; Sheervalilou R
Med Oncol; 2021 Aug; 38(9):114. PubMed ID: 34390411
[TBL] [Abstract][Full Text] [Related]
20. Identification of Keratinocyte Differentiation-Involved Genes for Metastatic Melanoma by Gene Expression Profiles.
Li K; Guo S; Tong S; Sun Q; Jin S; Qi B; Shao Y; Xu N
Comput Math Methods Med; 2021; 2021():9652768. PubMed ID: 35003328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
